Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'.

التفاصيل البيبلوغرافية
العنوان: Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'.
المؤلفون: Gayle S; Cybrexa Therapeutics, New Haven, CT 06511, USA., Aiello R; Cybrexa Therapeutics, New Haven, CT 06511, USA., Leelatian N; Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA., Beckta JM; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA., Bechtold J; Cybrexa Therapeutics, New Haven, CT 06511, USA., Bourassa P; Cybrexa Therapeutics, New Haven, CT 06511, USA., Csengery J; Cybrexa Therapeutics, New Haven, CT 06511, USA., Maguire RJ; Cybrexa Therapeutics, New Haven, CT 06511, USA., Marshall D; Cybrexa Therapeutics, New Haven, CT 06511, USA., Sundaram RK; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA., Van Doorn J; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA., Jones K; Cybrexa Therapeutics, New Haven, CT 06511, USA., Moore H; Cybrexa Therapeutics, New Haven, CT 06511, USA., Lopresti-Morrow L; Cybrexa Therapeutics, New Haven, CT 06511, USA., Paradis T; Cybrexa Therapeutics, New Haven, CT 06511, USA., Tylaska L; Cybrexa Therapeutics, New Haven, CT 06511, USA., Zhang Q; Cybrexa Therapeutics, New Haven, CT 06511, USA., Visca H; Physics Department, University of Rhode Island, Kingston, RI 02881, USA., Reshetnyak YK; Physics Department, University of Rhode Island, Kingston, RI 02881, USA., Andreev OA; Physics Department, University of Rhode Island, Kingston, RI 02881, USA., Engelman DM; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06511, USA., Glazer PM; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA., Bindra RS; Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA., Paralkar VM; Cybrexa Therapeutics, New Haven, CT 06511, USA.
المصدر: NAR cancer [NAR Cancer] 2021 Dec 07; Vol. 3 (4), pp. zcab047. Date of Electronic Publication: 2021 Dec 07 (Print Publication: 2021).
نوع المنشور: Published Erratum
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Oxford : Oxford University Press, [2019]-
مستخلص: [This corrects the article DOI: 10.1093/narcan/zcab021.].
(© The Author(s) 2021. Published by Oxford University Press on behalf of NAR Cancer.)
التعليقات: Erratum for: NAR Cancer. 2021 Jun 04;3(2):zcab021. (PMID: 34316708)
معلومات مُعتمدة: R01 CA215453 United States CA NCI NIH HHS; R01 GM073857 United States GM NIGMS NIH HHS
تواريخ الأحداث: Date Created: 20211210 Latest Revision: 20211212
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8651162
DOI: 10.1093/narcan/zcab047
PMID: 34888524
قاعدة البيانات: MEDLINE
الوصف
تدمد:2632-8674
DOI:10.1093/narcan/zcab047